By Susanna Moon
Chicago, Oct. 26 – JPMorgan Chase Financial Co. LLC priced $1.33 million of autocallable contingent interest notes due Oct. 21, 2021 linked to the lesser performing of the stocks of Abbott Laboratories and Gilead Sciences, Inc., according to a 424B2 filing with the Securities and Exchange Commission.
The notes will pay a contingent quarterly coupon at an annual rate of 9.5% if each stock closes at or above its 70% coupon barrier on the review date for that quarter.
The notes will be called at par plus the contingent coupon if each stock closes at or above its initial level on any review date other than the final date.
The payout at maturity will be par unless either stock finishes below its 70% trigger level, in which case investors will be fully exposed to any losses of the worse performing stock.
The notes are guaranteed by JPMorgan Chase & Co.
J.P. Morgan Securities LLC is the agent.
| Issuer: | JPMorgan Chase Financial Co. LLC
|
| Guarantor: | JPMorgan Chase & Co.
|
| Issue: | Autocallable contingent interest notes
|
| Underlying stocks: | Abbott Laboratories (Symbol: ABT) and Gilead Sciences, Inc. (Symbol: GILD)
|
| Amount: | $1.33 million
|
| Maturity: | Oct. 21, 2021
|
| Coupon: | 9.5% annualized, payable quarterly if each stock closes at or above 70% coupon barrier on review date for that quarter
|
| Price: | Par
|
| Payout at maturity: | Par unless either stock closes below 70% trigger, in which case 1% loss for each 1% decline of worse performing stock
|
| Call: | At par plus contingent coupon if each stock closes at or above initial level on any review date other than final date
|
| Initial levels: | $70.95 for Abbott, $76.31 for Gilead
|
| Trigger levels: | $49.665 for Abbott, $53.417 for Gilead, 70% of initial levels
|
| Pricing date: | Oct. 16
|
| Settlement date: | Oct. 19
|
| Agent: | J.P. Morgan Securities LLC
|
| Fees: | 2.75%
|
| Cusip: | 48130U6N0
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
